NEWS & EVENTS

Latest news and upcoming events

Ysios Capital ESG Report
20 Nov 2024

Ysios Capital ESG Report

Upcoming events

  • Brain Innovation Days
    13 - 14 November 2024,
    Brussels

    download

  • Congreso CIBER
    27 - 24 November 2024
    Valencia

    download

  • Bio-Neuroscience
    25 - 27 February 2025
    Amsterdam

    download

  • 18th Annual European Life Sciences CEO Forum
    26 - 27 February 2025
    Zurich

    download
13 Sep 2011

Ysios Capital Partners leads €29.2million Series D Financing of AM-Pharma

Barcelona, Spain, 13 September 2011 – Ysios Capital Partners, the Spanish life sciences venture capital firm, today announces that is has led the €29.2 million Series D financing of AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) as a treatment of severe inflammatory diseases.
15 Jun 2011

Ysios Capital Partners leads €2million series A financing of STAT Diagnostica

Barcelona 15th June 2011 - Ysios Capital Partners today announces that it has led a €2M Series A investment in STAT Diagnostica, a company based in the Barcelona Science Park.
24 Jan 2011

Amgen to acquire Biovex for up to $1 bn

THOUSAND OAKS, Calif., and WOBURN, Mass. (Jan. 24, 2011) – Amgen (NASDAQ: AMGN) and BioVex Group, Inc. today announced that the companies have entered into a definitive acquisition agreement under which Amgen has agreed to acquire BioVex Group, Inc., a privately held, venture-funded, biotechnology company headquartered in Woburn, Mass. BioVex is developing OncoVEXGM-CSF, a novel oncolytic vaccine in Phase 3 clinical development, that may represent a new approach to treating melanoma and head and neck cancer.
21 Sep 2010

Ysios Capital Partners leads €5million Series A Financing of Sabirmedical

Ysios Capital Partners leads € 5 Million
21 Sep 2010

Ysios Capital Partners leads €5million Series A Financing of Sabirmedical

BARCELONA 23th September 2010. Ysios Capital Partners today announces that it has led the Series A investment of Sabirmedical, company based in the Barcelona Science Park developing medical devices and sensor technologies.
10 May 2010

Ysios Capital Partners participates in Cardoz’ €10million Series A financing round.

Cardoz AB, a clinical stage company, today announced that it has closed a series A financing round of SEK 100 million (€ 10 million) with an international syndicate of venture capital investors.
10 May 2010

Ysios Capital Partners participates in Cardoz’ €10million Series A financing round.

Cardoz AB, a clinical stage company, today announced that it has closed a series A financing round of SEK 100 million (€ 10 million) with an international syndicate of venture capital investors.
10 Nov 2009

Ysios Capital Partners participates in Biovex’s $70million final closing

Woburn, MA, November 10, 2009 ‐‐ BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March.
10 Nov 2009

Ysios Capital Partners participates in Biovex’s $70million final closing

Woburn, MA, November 10, 2009 ‐‐ BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March.
Laia Crespo joins Ysios Capital Partners as Investment Manager<
28 Sep 2009

Laia Crespo joins Ysios Capital Partners as Investment Manager

Main responsibilities of Laia Crespo will include the identification and assessment of investment and disinvestment opportunities from the scientific and business perspectives

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Для комфортной игры важна надежное и проверенное casino. Joycasino официальный сайт предлагает пользователям обширный выбор слотов, приветственные бонусы и качественный сервис 24/7 для увлекательного и безопасного времяпрепровождения.